Caricamento...
A Randomized Controlled Trial of Intranasal Neuropeptide Y in Patients With Major Depressive Disorder
BACKGROUND: Since about one-third of patients with major depressive disorder (MDD) do not respond adequately to available antidepressants, there is a need for treatments based on novel mechanisms of action. Neuropeptide Y (NPY), a normal brain constituent, is reduced in cerebrospinal fluid of patien...
Salvato in:
| Pubblicato in: | Int J Neuropsychopharmacol |
|---|---|
| Autori principali: | , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Oxford University Press
2020
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7770516/ https://ncbi.nlm.nih.gov/pubmed/33009815 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ijnp/pyaa054 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|